DOI:
10.1055/s-00000002
Aktuelle Dermatologie
LinksClose Window
References
Kaufman HL. et al.
Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial.
J Immunother Cancer 2018;
6: 7
We do not assume any responsibility for the contents of the web pages of other providers.